Latest news
Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. -- Barrons.com - MoomooMoomoo · Sat, 08 Aug 2026 00:16:29 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - Barron'sBarron's · Fri, 07 Aug 2026 19:33:00 GMTModerna mRNA flu shot wins FDA approval but awaits CDC recommendations - Pharmaceutical TechnologyPharmaceutical Technology · Fri, 07 Aug 2026 17:32:19 GMTHAYA’s FDA fast-track win puts heart aging in focus - Longevity.TechnologyLongevity.Technology · Fri, 07 Aug 2026 13:38:35 GMTFDA Approves First MRNA Flu Vaccine in Win for Moderna After Arduous Review -- 2nd Update - MoomooMoomoo · Fri, 07 Aug 2026 10:45:19 GMTUS FDA approves Replimune’s skin cancer drug after prior rejections - WNWN-FMWNWN-FM · Fri, 07 Aug 2026 02:36:12 GMTReplimune rebounds to win FDA approval of melanoma drug - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 21:16:19 GMTModerna Slumps Despite FDA Win; Will Its Sprint Restart? - Investor's Business DailyInvestor's Business Daily · Thu, 06 Aug 2026 20:09:00 GMT